about
Mannose 6-phosphate receptor and sortilin mediated endocytosis of α-galactosidase A in kidney endothelial cellsLipid profile in adult patients with Fabry disease - Ten-year follow upStroke and Fabry disease.White matter lesions and vascular cognitive impairment: part 1: typical and unusual causes.Cognitive and psychological functioning in Fabry disease.Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies.Fabry disease and early strokeCognitive function in adults aging with fabry disease: a case-control feasibility study using telephone-based assessments.Positron Emission Tomography and Magnetic Resonance Imaging of the Brain in Fabry Disease: A Nationwide, Long-Time, Prospective Follow-Up.Establishment and characterization of Fabry disease endothelial cells with an extended lifespan.Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells.Fibrosis: a key feature of Fabry disease with potential therapeutic implicationsAgalsidase alfa (Replagal) in the treatment of Anderson-Fabry diseaseVascular dysfunction in the alpha-galactosidase A-knockout mouse is an endothelial cell-, plasma membrane-based defect.Lysosomal storage disease: revealing lysosomal function and physiology.Neurological features of Fabry disease: clinical, pathophysiological aspects and therapy.Fabry disease: raising awareness of the disease among physicians.Aetiological diagnosis of middle-aged and elderly cryptogenic ischaemic cerebral vascular disease.Neurocutaneous Disorders for the Practicing Neurologist: a Focused Review.Endothelial cell dysfunction in globoid cell leukodystrophy.Fabry Disease: Recognition, Diagnosis, and Treatment of Neurological Features.Lysosomal delivery of therapeutic enzymes in cell models of Fabry disease.Enzyme replacement therapy in a patient with Fabry disease and the development of IgE antibodies against agalsidase beta but not agalsidase alpha.Fabry disease; early diagnosis improves prognosis but diagnosis is often delayed.p.E66Q mutation in the GLA gene is associated with a high risk of cerebral small-vessel occlusion in elderly Japanese males.Redefining the Pulvinar Sign in Fabry Disease.Diffusion tensor imaging and brain volumetry in Fabry disease patients.Fabry disease and Factor V Leiden: a potent vascular risk combination.Early cerebral manifestations in a young female with Fabry disease with skewed X-inactivation.
P2860
Q28727768-088EC793-8CB6-4915-A051-037BA47639FEQ33904518-0441B702-BBA1-4E59-9F0E-D37703F41B83Q34061632-5AB44828-B7DB-4724-B232-D7A94E874513Q34156950-EEA42075-7AA9-441F-87F0-359BC19FDCDAQ34665708-58BAAAB0-5469-42B4-8B59-55482D8C2567Q35028532-C3491C36-050C-4A77-B630-873C48F0FDBCQ35110216-68C0C1BC-8EC0-404B-9CA2-1AA0303BBC43Q35183095-DD138498-6B8F-40A9-AC56-030413D61457Q35858698-37AEE049-9252-4DAD-96D1-C34CA5C49EBBQ36116909-3A8BF93C-AC9B-4792-B286-CE8DE05813E7Q36995447-006BA2D8-EDDA-4932-9695-9FF4E186A55EQ37113004-DE54CDEE-092F-478C-936E-95DF8A8E215EQ37290507-E7F0550F-889C-44C8-9D03-F3D9A78D6F33Q37347258-54992370-3CD2-44E4-B800-3A5D8094EEA9Q37739706-C4635B4E-A791-499E-9E54-FF9DE4F206A6Q37994740-956A1A9A-89B3-4126-99CF-C88832E7E05FQ38052848-95AB57EF-59FC-4FF5-9CB6-E31DB4D8C3DAQ38500772-A3EDF5D3-055C-4EBD-80A4-DBD1041C1AFCQ38694212-E128951E-B84E-490B-9A0B-722B1D33E8B0Q38796127-33983544-72F4-4EE1-8AB2-D942740B923BQ38844401-A6FA52FA-76B1-4192-A592-D09885BDD655Q39373577-01D999D4-8664-46A1-9315-87AE06DE7FE0Q40355885-2EBABE4A-F458-415C-9C9C-A93D16DA505BQ41905133-BA4C1AC5-F9D8-4A98-A09C-9119ABAEDC12Q45236280-1B906B8E-8671-4CD4-9CAF-01568F080BD5Q48010788-39F99D27-5138-4765-A3B9-E2F51DA3A0D1Q48223989-4BB03A0E-D2A1-44F0-991C-E24BF89C2F70Q48664517-213CE585-A04A-4D58-B908-34180138F627Q51368431-25FCA3AF-4564-4A81-89D7-1D846E54A94F
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The cerebral vasculopathy of Fabry disease.
@ast
The cerebral vasculopathy of Fabry disease.
@en
type
label
The cerebral vasculopathy of Fabry disease.
@ast
The cerebral vasculopathy of Fabry disease.
@en
prefLabel
The cerebral vasculopathy of Fabry disease.
@ast
The cerebral vasculopathy of Fabry disease.
@en
P2093
P1476
The cerebral vasculopathy of Fabry disease
@en
P2093
David F Moore
Hasan Askari
Raphael Schiffmann
P304
P356
10.1016/J.JNS.2007.01.053
P577
2007-03-23T00:00:00Z